Pages that link to "Q40926909"
Jump to navigation
Jump to search
The following pages link to Characterization of physiologically regulated vectors for the treatment of ischemic disease (Q40926909):
Displaying 36 items.
- Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization (Q30939880) (← links)
- A novel chimeric promoter that is highly responsive to hypoxia and metals (Q33233475) (← links)
- Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation (Q34013802) (← links)
- A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. (Q34113282) (← links)
- Can gene therapy overcome the problem of hypoxia in radiotherapy? (Q34157875) (← links)
- Bioreductive and gene therapy approaches to hypoxic diseases (Q34455176) (← links)
- Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model. (Q34679148) (← links)
- A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy (Q34779805) (← links)
- Cytochrome P450-based cancer gene therapy: current status (Q35040837) (← links)
- Regulated production of proteins from muscle using gene transfer: potential therapeutic applications (Q35093620) (← links)
- Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression (Q36431079) (← links)
- Employing tumor hypoxia for oncolytic therapy in breast cancer (Q36529889) (← links)
- Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1 (Q36646254) (← links)
- AAV-mediated gene transfer for retinal diseases (Q36708300) (← links)
- Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element (Q36876347) (← links)
- Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy (Q37137456) (← links)
- Double oxygen-sensing vector system for robust hypoxia/ischemia-regulated gene induction in cardiac muscle in vitro and in vivo (Q37276419) (← links)
- Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target (Q37439503) (← links)
- Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart. (Q37643467) (← links)
- Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy (Q38350071) (← links)
- Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment (Q39851910) (← links)
- Rational design of minimal hypoxia-inducible enhancers (Q39993338) (← links)
- Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vector (Q40003426) (← links)
- Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy (Q40440792) (← links)
- Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor (Q40499227) (← links)
- Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy (Q40756796) (← links)
- Hypoxia-inducible transgene expression in differentiated human NT2N neurons--a cell culture model for gene therapy of postischemic neuronal loss. (Q40778617) (← links)
- Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy (Q41925534) (← links)
- Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy (Q43767321) (← links)
- Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. (Q44168577) (← links)
- Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases (Q44249554) (← links)
- Hypoxia-mediated tumour targeting (Q44368762) (← links)
- A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia (Q45882286) (← links)
- Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells (Q45882787) (← links)
- A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy (Q48340796) (← links)
- Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis (Q51639478) (← links)